Number and function of circulating endothelial progenitor cells and calcitonin gene-related peptide in hypertension: Support from and opportunities in Bartters and Gitelmans syndromes patients

Journal of Hypertension

Volumn 28, Issue 10, 2010, Pages 2169-2170

  Calò, Lorenzo A ^a   Davis, Paul A ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE;

BARTTER SYNDROME; CELL AGING; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; GITELMAN SYNDROME; HUMAN; HYPERTENSION; LETTER; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; STEM CELL;

EID: 77957252258     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32833d136c     Document Type: Letter

References (17)

1. Zhou Z, Peng J, Wang C-J, Li D, Li T-T, Hu C-P, et al. Accelerated senescence of endothelial progenitor cells in hypertension is related to the reduction of calcitonin gene-related peptide. J Hypertens 2010; 28:931-939.
2. Imanishi T, Moriwaki C, Hano T, Nishio I. Endothelial progenitor cell senescence is accelerated in both experimental hypertensive rats and patients with essential hypertension. J Hypertens 2005; 23:1831-1837.
3. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005; 353:999-1007. (Pubitemid 41262334)
4. Yao E-H, Fukuda N, Matsumoto T, Kobayashi N, Katakawa M, Yamamoto C, et al. Losartan improves the impaired function of endothelial progenitor cells in hypertension via an antioxidant effect. Hypertens Res 2007; 30:1119-1128.
5. Honda A, Matsuura K, Fukushima N, Tsurumi Y, Kasanuki H, Hagiwara N. Telmisartan induces proliferation of human endothelial progenitor cells via PPARg-dependent PI3K/Akt pathway. Atherosclerosis 2009; 205:376384.
6. Hadoke PWF. Is endothelial progenitor cell senescence a therapeutic target in hypertension? J Hypertens 2010; 28:887-888.
7. Calo LA, Pessina AC. RhoA/Rho-kinase pathway: much more than just a modulation of vascular tone. Evidence from studies in humans. J Hypertens 2007; 25:259-264.
8. Calo LA, Puato M, SchiavoS, Zanardo M, Tirrito C, Pagnin E, et al. Absence of vascular remodelling in a high angiotensin-II state (Bartter's and Gitelman's syndromes): implications for angiotensin II signalling pathways. Nephrol Dial Transplant 2008; 23:2804-2809.
9. Calo LA, Montisci R, Scognamiglio R, Davis PA, Pagnin E, Schiavo S, et al. High angiotensin II state without cardiac remodeling (Bartter's and Gitelman's syndromes): are angiotensin II type 2 receptors involved? J Endocrinol Invest 2009; 32:832-836.
10. Calo LA, Pagnin E, Davis PA, Sartori M, Semplicini A. Oxidative stress related factors in Bartter's and Gitelman's syndromes: relevance for angiotensin II signalling. Nephrol Dial Transplant 2003; 18:15181525.
11. Wu BJ, Midwinter RG, Cassano C, Beck K, Wang Y, Changsiri D, et al. Heme oxygenase-1 increases endothelial progenitor cells. Arterioscler Thromb Vasc Biol 2009; 29:1537-1542.
12. Peng J, Lu R, Ye F, Deng H-W, Li Y-J. The heme oxygenase pathway is involved in calcitonin gene-related peptide-mediated delayed cardioprotection induced by monophosphoryl lipid A in rats. Regul Pept 2002; 103:1-7. (Pubitemid 34001630)
13. Calo LA. Vascular tone control in humans: the utility of studies in Bartter's/ Gitelman's syndromes. Kidney Int 2006; 69:963-966.
14. Calo LA, Pessina AC, Semplicini A. Angiotensin II signaling in the Bartter's and Gitelman's syndromes, a negative human model of hypertension. High Blood Press Cardiovasc Prev 2005; 12:17-26.
15. Calo LA, Schiavo S, Davis PA, Pagnin E, Mormino P, D'Angelo A, Pessina AC. Angiotensin II signaling via type 2 receptors in a human model of vascular hyporeactivity: implications for hypertension. J Hypertens 2010; 28:111-118.
16. Calo L, Sartore G, Bassi A, Basso C, Bertocco S, Marin R, et al. Reduced susceptibility of low density lipoprotein to oxidation in patients with overproduction of nitric oxide (Bartter's and Gitelman's syndrome). J Hypertens 1998; 16:1001-1008.
17. Rosso A, Balsamo A, Gambino R, Dentelli P, Falcioni R, Cassader M, et al. p53 Mediates the accelerated onset of senescence of endothelial progenitor cells in diabetes. J Biol Chem 2006; 281:4339-4347.